High expression of GPNMB indicates an unfavorable prognosis in glioma: Combination of data from the GEO and CGGA databases and validation in tissue microarray

Glycoprotein non-metastatic melanoma protein B (GPNMB), a transmembrane glycoprotein, has been reported to be involved in tumor progression, but its prognostic value for glioma and the mechanistic effects on glioma progression have not been clearly explored. The present study aimed to investigate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Xiao, Zhang, Lina, Ke, Shanbao, Liu, Tao, Hao, Liuwei, Zhao, Pan, Tu, Wenzhi, Cang, Shundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400985/
https://www.ncbi.nlm.nih.gov/pubmed/32782553
http://dx.doi.org/10.3892/ol.2020.11787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400985/
https://www.ncbi.nlm.nih.gov/pubmed/32782553
http://dx.doi.org/10.3892/ol.2020.11787

Ejemplares similares